Literature DB >> 22549042

Familial hemiplegic migraine type 1 mutations W1684R and V1696I alter G protein-mediated regulation of Ca(V)2.1 voltage-gated calcium channels.

Edgar Garza-López1, Alejandro Sandoval, Ricardo González-Ramírez, María A Gandini, Arn Van den Maagdenberg, Michel De Waard, Ricardo Felix.   

Abstract

Familial hemiplegic migraine type 1 (FHM-1) is a monogenic form of migraine with aura that is characterized by recurrent attacks of a typical migraine headache with transient hemiparesis during the aura phase. In a subset of patients, additional symptoms such as epilepsy and cerebellar ataxia are part of the clinical phenotype. FHM-1 is caused by missense mutations in the CACNA1A gene that encodes the pore-forming subunit of Ca(V)2.1 voltage-gated Ca(2+) channels. Although the functional effects of an increasing number of FHM-1 mutations have been characterized, knowledge on the influence of most of these mutations on G protein regulation of channel function is lacking. Here, we explored the effects of G protein-dependent modulation on mutations W1684R and V1696I which cause FHM-1 with and without cerebellar ataxia, respectively. Both mutations were introduced into the human Ca(V)2.1α(1) subunit and their functional consequences investigated after heterologous expression in human embryonic kidney 293 (HEK-293) cells using patch-clamp recordings. When co-expressed along with the human μ-opioid receptor, application of the agonist [d-Ala2, N-MePhe4, Gly-ol]-enkephalin (DAMGO) inhibited currents through both wild-type (WT) and mutant Ca(V)2.1 channels, which is consistent with the known modulation of these channels by G protein-coupled receptors. Prepulse facilitation, which is a way to characterize the relief of direct voltage-dependent G protein regulation, was reduced by both FHM-1 mutations. Moreover, the kinetic analysis of the onset and decay of facilitation showed that the W1684R and V1696I mutations affect the apparent dissociation and reassociation rates of the Gβγ dimer from the channel complex, suggesting that the G protein-Ca(2+) channel affinity may be altered by the mutations. These biophysical studies may shed new light on the pathophysiology underlying FHM-1.
© 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22549042     DOI: 10.1016/j.bbadis.2012.04.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

Review 1.  Headache and epilepsy.

Authors:  P R Bauer; J A Carpay; G M Terwindt; J W Sander; R J Thijs; J Haan; G H Visser
Journal:  Curr Pain Headache Rep       Date:  2013-08

Review 2.  Migrainomics - identifying brain and genetic markers of migraine.

Authors:  Dale R Nyholt; David Borsook; Lyn R Griffiths
Journal:  Nat Rev Neurol       Date:  2017-11-17       Impact factor: 42.937

Review 3.  Migraine in the era of precision medicine.

Authors:  Lv-Ming Zhang; Zhao Dong; Sheng-Yuan Yu
Journal:  Ann Transl Med       Date:  2016-03

4.  The E1015K variant in the synprint region of the CaV2.1 channel alters channel function and is associated with different migraine phenotypes.

Authors:  Steven B Condliffe; Alessandra Fratangeli; Nehan R Munasinghe; Elena Saba; Maria Passafaro; Cristina Montrasio; Maurizio Ferrari; Patrizia Rosa; Paola Carrera
Journal:  J Biol Chem       Date:  2013-10-09       Impact factor: 5.157

5.  Studies on the pathophysiology and genetic basis of migraine.

Authors:  Claudia F Gasparini; Heidi G Sutherland; Lyn R Griffiths
Journal:  Curr Genomics       Date:  2013-08       Impact factor: 2.236

6.  The de novo CACNA1A pathogenic variant Y1384C associated with hemiplegic migraine, early onset cerebellar atrophy and developmental delay leads to a loss of Cav2.1 channel function.

Authors:  Maria A Gandini; Ivana A Souza; Laurent Ferron; A Micheil Innes; Gerald W Zamponi
Journal:  Mol Brain       Date:  2021-02-08       Impact factor: 4.041

Review 7.  Comorbid Bipolar Disorder and Migraine: From Mechanisms to Treatment.

Authors:  Jinfeng Duan; Rongmei Yang; Wenwen Lu; Lingfei Zhao; Shaohua Hu; Chenxia Hu
Journal:  Front Psychiatry       Date:  2021-01-11       Impact factor: 4.157

8.  Case-control study of ADARB1 and ADARB2 gene variants in migraine.

Authors:  Claudia F Gasparini; Heidi G Sutherland; Bridget Maher; Astrid J Rodriguez-Acevedo; Elhame Khlifi; Larisa M Haupt; Lyn R Griffiths
Journal:  J Headache Pain       Date:  2015-04-03       Impact factor: 7.277

Review 9.  Epilepsy and migraine-Are they comorbidity?

Authors:  Jin Liao; Xin Tian; Hao Wang; Zheng Xiao
Journal:  Genes Dis       Date:  2018-05-05

Review 10.  Episodic Ataxias: Faux or Real?

Authors:  Paola Giunti; Elide Mantuano; Marina Frontali
Journal:  Int J Mol Sci       Date:  2020-09-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.